InsiderClue
← All stocks

EXELIXIS, INC.

EXEL Net selling
CIK 0000939767 #814 in the set updated 18 Sep 2026
Bought (120 mo)
$16.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$349.82M
$12.08M on a plan · $240.94M straight out of an exercise
Sold at will
$96.81M
131 of 440 sales
Net
−$333.37M
−$80.35M against sales at will

By person

27 insiders · 499 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORRISSEY MICHAEL
President and CEO
—
$58.19M (59) scheduled
−$58.19M
3,810,385
1.54%
$204.47M
+520.8%
Haley Patrick J.
EVP, Commercial
—
$35.85M (70)
−$35.85M
357,638
0.1443%
$19.19M
+68.7%
Schwab Gisela
Pres, Prod Dev & Med Aff & CMO
—
$34.69M (36) scheduled
−$34.69M
689,078
0.2781%
$36.98M
+375.7%
Hessekiel Jeffrey
EVP & General Counsel
—
$28.18M (41) scheduled
−$28.18M
693,396
0.2798%
$37.21M
+191.6%
Lamb Peter
EVP, Scientific Strategy & CSO
—
$27.46M (26) scheduled
−$27.46M
410,958
0.1659%
$22.05M
+616.6%
Senner Christopher J.
EVP and CFO
—
$24.02M (17) scheduled
−$24.02M
952,317
0.3843%
$51.10M
+887.5%
SCANGOS GEORGE A
Director
—
$23.44M (42)
−$23.44M
714,717
0.2884%
$38.35M
−45.3%
PAPADOPOULOS STELIOS
Director
—
$16.81M (16)
−$16.81M
1,197,595
0.4833%
$64.26M
−3.3%
Aftab Dana
EVP, Research and Development
—
$16.67M (13)
−$16.67M
594,741
0.2400%
$31.91M
+131.3%
JOHNSON DAVID EDWARD
Director
$16.46M (5)
$2.60M (1)
+$13.85M
1,571,438
0.6342%
$84.32M
+72.5%
POSTE GEORGE
Director
—
$12.00M (15) scheduled
−$12.00M
127,199
0.0513%
$6.83M
+64.0%
WILLSEY LANCE
Director
—
$10.20M (13)
−$10.20M
424,415
0.1713%
$22.77M
−25.3%
MARCHESI VINCENT T
Director
—
$8.70M (12) scheduled
−$8.70M
93,989
0.0379%
$5.04M
−21.7%
Smith Julie
Director
—
$8.07M (6) scheduled
−$8.07M
28,957
0.0117%
$1.55M
—
WYSZOMIERSKI JACK L
Director
—
$7.73M (14) scheduled
−$7.73M
284,384
0.1148%
$15.26M
+317.5%
COHEN CHARLES
Director
—
$7.42M (8)
−$7.42M
261,375
0.1055%
$14.03M
+5.3%
Garber Alan M
Director
—
$7.13M (14) scheduled
−$7.13M
35,703
0.0144%
$1.92M
−39.7%
FELDBAUM CARL B
Director
—
$6.83M (14) scheduled
−$6.83M
18,701
0.0075%
$1.00M
−61.6%
Peterson Amy C.
EVP Prod Dev & Med Aff & CMO
—
$3.31M (1) scheduled
−$3.31M
465,393
0.1878%
$24.97M
—
Freire Maria C
Director
—
$2.92M (4) scheduled
−$2.92M
109,186
0.0441%
$5.86M
—
Beckerle Mary C
Director
—
$2.36M (6) scheduled
−$2.36M
16,079
0.0065%
$862.80K
—
Oliver Bob
Director
—
$2.02M (3) scheduled
−$2.02M
29,487
0.0119%
$1.58M
—
Eckhardt Sue Gail
Director
—
$1.87M (6) scheduled
−$1.87M
16,079
0.0065%
$862.80K
—
Hefti Brenda
SVP and General Counsel
—
$1.15M (2) scheduled
−$1.15M
106,762
0.0431%
$5.73M
+17.8%
Heyman Tomas J.
Director
—
$201.25K (1)
−$201.25K
50,649
0.0204%
$2.72M
—
Goodman Vicki L
EVP, Prod Dev & Med Aff &CMO
—
—
—
307,654
0.1242%
$16.51M
—
Wright Jacqueline
Director
—
—
—
51,756
0.0209%
$2.78M
—

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Beckerle Mary C
10 Aug 2026
Director
Sold on a plan
9,812
$53.66
$526.51K
Eckhardt Sue Gail
1 Jun 2026
Director
Sold on a plan
9,812
$50.14
$491.97K
WYSZOMIERSKI JACK L
1 Jun 2026
Director
Sold on a plan
3,925
$50.55
$198.41K
Hefti Brenda
18 May 2026
SVP and General Counsel
Sold on a plan
6,625
$50.21
$332.64K
Hefti Brenda
18 Feb 2026
SVP and General Counsel
Sold on a plan
18,669
$44.01
$821.62K
Eckhardt Sue Gail
13 Feb 2026
Director
Sold on a plan
3,856
$43.79
$168.85K
WYSZOMIERSKI JACK L
3 Jun 2025
Director
Sold on a plan
7,535
$43.09
$324.68K
Eckhardt Sue Gail
2 Jun 2025
Director
Sold on a plan
4
$43.67
$174.68
Eckhardt Sue Gail
2 Jun 2025
Director
Sold on a plan
18,834
$42.74
$804.97K
Haley Patrick J.
14 May 2025
EVP, Commercial
Sold on a plan
10,000
$42.68
$426.80K
Aftab Dana
1 May 2025
CSO/EVP Disc & Trans Research
Sold on a plan
1,508
$39.00
$58.81K
Haley Patrick J.
3 Mar 2025
EVP, Commercial
Sold on a plan
10,000
$38.80
$388.00K
Haley Patrick J.
22 Nov 2024
EVP, Commercial
Sold on a plan
10,000
$35.27
$352.70K
Haley Patrick J.
18 Nov 2024
EVP, Commercial
Sold on a plan
19,381
$34.41
$666.90K
Haley Patrick J.
18 Nov 2024
EVP, Commercial
Sold on a plan
22,207
$34.31
$761.92K
Hessekiel Jeffrey
1 Nov 2024
EVP & General Counsel
Sold on a plan
50,000
$34.13
$1.71M
Aftab Dana
30 Oct 2024
CSO/EVP Disc & Trans Research
Sold on a plan
1,162
$31.40
$36.49K
Hessekiel Jeffrey
28 Oct 2024
EVP & General Counsel
Sold on a plan
25,000
$28.39
$709.75K
Hessekiel Jeffrey
23 Sep 2024
EVP & General Counsel
Sold on a plan
25,000
$26.38
$659.50K
Haley Patrick J.
7 Aug 2024
EVP, Commercial
Sold on a plan
14,000
$25.50
$357.00K
WYSZOMIERSKI JACK L
4 Jun 2024
Director
Sold on a plan
8,287
$22.00
$182.31K
Hessekiel Jeffrey
13 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$23.01
$575.25K
Haley Patrick J.
12 Dec 2023
EVP, Commercial
Sold on a plan
14,149
$22.50
$318.35K
Hessekiel Jeffrey
4 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.06
$551.50K
Hessekiel Jeffrey
30 Nov 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.01
$550.25K
Aftab Dana
30 Aug 2023
CSO/EVP Disc & Trans Research
Sold on a plan
4,600
$22.47
$103.36K
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 712
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,691,176
Sales filed before the plan box existed 101
History held since 2 Sep 2016